Skip to content
For laboratory research use only · Not for human consumption
Pioneer Labs

Hormone analogs / Research guide

TRZ.

A little deeper. A clearer picture.

One modified peptide with two receptor targets. TRZ, originally LY3298176, was developed as a dual agonist: two receptor activities combined in one molecule.

For research use onlyView TRZ sizes
Published by Pioneer LabsUpdated Sources & editorial standards

01 / Molecular architecture

A closer look at the chain.

The reference uses a fatty-acid-modified peptide design. Dual agonist refers to receptor activity, not two peptides blended together in a vial.

Pioneer / Reference notesMolecular features
  • Single modified peptide
  • Dual agonist
  • Fatty-acid side chain
Structural features shown schematically, not a full sequence or three-dimensional model.

Reference information: [1][2]. Actual lot identity must be verified separately.

Dual activity in one modified molecule.

The term dual agonist describes two experimental receptor targets for TRZ. It does not identify separate ingredients in a formulation. Its modified peptide structure is one molecular identity, while the receptor profile describes how that identity is investigated in different assay systems.

Different signals from the same receptor context.

The cited study compares signaling readouts, including cAMP and beta-arrestin recruitment. These readouts capture different events. A receptor response depends on the measured signal and comparison conditions, so dual agonist should not be read as equal potency at both receptors or as identical behavior across all endpoints.

Structure and research references: [1]

02 / Read the evidence

Research & analytical context.

Cell-based receptor studies compare signaling at the two receptor targets using defined assay systems. Dual activity does not mean equal potency at both receptors. The receptor preparation and measured signal matter when interpreting a comparison.

Read the references: [1][2].

The distinction that matters

TRZ’s two-target reference profile differs from RT’s three-target profile. These are distinct modified peptides; receptor findings do not establish batch identity or purity.

03 / From reference to record

Know the lot, too.

A publication describes its own test material. Your lot’s certificate describes what was tested on that lot. Keep the compound name, batch number and reported methods together when reviewing a result.

Identity & composition

Check sequence or chemical form, terminal modifications, counterion and—where relevant—each blend component.

Analytical results

Read purity, content, sterility and endotoxin results as separate measurements. Only call a test passed when the actual report supports it.

Handling & storage notes

Lyophilized material: Store at −20°C; protect from light and moisture.

Follow the material-specific label and supporting storage documentation. These temperatures do not establish a shelf life.

How to store lyophilized peptides

04 / Reference questions

A few details, explained.

Does dual agonist mean a fifty-fifty mixture?

No. TRZ is a single modified peptide. Dual refers to the two receptor targets, not a mass ratio between two separate compounds.

How is this different from RT’s three-target description?

RT’s reference profile has three receptor targets where TRZ’s has two. The target count describes different research profiles; it is not a ranking or a substitute for comparing the underlying structures and assays.

Read alongside the references: [1]

05 / Continue reading

Go to the source.